Donia Y. Abeid
Research Subjects
Research Interests
Donia Y. Abeid has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Chad J. Johnson
La Trobe University 7 La Trobe Bioimaging Platform Melbourne, VIC 3073
2 shared publications- Christina B. Wölwer
Institute of Pathology, University Hospital Cologne 6 , Cologne 50937
2 shared publications - Edwin D. Hawkins
Walter and Eliza Hall Institute of Medical Research, Parkville, Australia
2 shared publications - Krystle Y. B. Lim
La Trobe University 1 Department of Biochemistry & Chemistry Melbourne, VIC 3073
2 shared publications - Lucas M. Newton
La Trobe University 1 Department of Biochemistry & Chemistry Melbourne, VIC 3073
2 shared publications - Patrick O. Humbert
Affiliations Department of Biochemistry & Chemistry, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, Victoria, Australia, Department of Biochemistry & Pharmacology, University of Melbourne, Melbourne, Victoria, Australia, Department of Clinical Pathology, University of Melbourne, Melbourne, Victoria, Australia
2 shared publications
Latest Publications
- Open Access
- 9 April 2026
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 139 (12)
CDK9 interacts with a RanGTP–importin-β complex to regulate erythroid enucleation
Erythroid enucleation is the final stage of erythroid terminal differentiation and involves the separation of an orthochromatic erythroblast into two daughter cells – a pyrenocyte containing the extruded nucleus, and a reticulocyte, which will become a red blood cell. Our previous work has identified CDK9 as a regulator of erythroid enucleation that appears to act independently of its known role in regulating RNA polymerase II transcription, suggesting the potential for a new CDK9 role. Using a co-immunoprecipitation and mass spectrometry approach, we here identified the interactome of CDK9 in differentiating erythroblasts. We show that CDK9 interacts with a RanGTP–importin-β complex during erythroid terminal differentiation, and inhibition of importin-β in erythroblasts blocks erythroid enucleation. Using imaging analysis and functional assays of enucleating erythroblasts, we show that CDK9 and importin-β colocate at a crucial site of activity opposite to the nucleus before nuclear extrusion and we describe a novel finding that physically links CDK9 and importin-β activity prior to calmodulin and Ca2+ signalling, and subsequent F-actin activity, to achieve enucleation.
- 9 April 2026
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 139 (12)
Open AccessCDK9 interacts with a RanGTP–importin-β complex to regulate erythroid enucleation
Erythroid enucleation is the final stage of erythroid terminal differentiation and involves the separation of an orthochromatic erythroblast into two daughter cells – a pyrenocyte containing the extruded nucleus, and a reticulocyte, which will become a red blood cell. Our previous work has identified CDK9 as a regulator of erythroid enucleation that appears to act independently of its known role in regulating RNA polymerase II transcription, suggesting the potential for a new CDK9 role. Using a co-immunoprecipitation and mass spectrometry approach, we here identified the interactome of CDK9 in differentiating erythroblasts. We show that CDK9 interacts with a RanGTP–importin-β complex during erythroid terminal differentiation, and inhibition of importin-β in erythroblasts blocks erythroid enucleation. Using imaging analysis and functional assays of enucleating erythroblasts, we show that CDK9 and importin-β colocate at a crucial site of activity opposite to the nucleus before nuclear extrusion and we describe a novel finding that physically links CDK9 and importin-β activity prior to calmodulin and Ca2+ signalling, and subsequent F-actin activity, to achieve enucleation.
- Open Access
CDK9 interacts with a RanGTP-NEMP1-Importin-β complex to regulate erythroid enucleation
Erythroid enucleation is the final stage of erythroid terminal differentiation and involves the separation of an orthochromatic erythroblast into two daughter cells; a pyrenocyte containing the extruded nucleus, and a reticulocyte that will become a red blood cell. Our previous work identified CDK9 as a regulator of erythroid enucleation that appears to act independently of its known role in regulating RNA polymerase II transcription, suggesting the potential for a new CDK9 role. Using a co-immunoprecipitation and mass spectrometry approach, we identified the interactome of CDK9 in differentiating erythroblasts. We show that CDK9 interacts with a RanGTP-NEMP1-Importin-β complex during erythroid terminal differentiation, and inhibition of importin-β in erythroblasts blocks erythroid enucleation. Using imaging analysis and functional assays of enucleating erythroblasts, we show that CDK9 and importin-β co-locate at a critical site of activity opposite to the nucleus before nuclear extrusion and we describe a novel finding that physically links CDK9 and importin-β activity prior to CaM/Ca 2+ signalling and subsequent F-actin activity to achieve enucleation. Key Points: Importin-β physically interacts with CDK9 in erythroid cells and is a novel regulator of erythroid enucleation CDK9 and importin-β are required upstream of CaM/Ca 2+ signalling to enable nuclear extrusion
Open AccessCDK9 interacts with a RanGTP-NEMP1-Importin-β complex to regulate erythroid enucleation
Erythroid enucleation is the final stage of erythroid terminal differentiation and involves the separation of an orthochromatic erythroblast into two daughter cells; a pyrenocyte containing the extruded nucleus, and a reticulocyte that will become a red blood cell. Our previous work identified CDK9 as a regulator of erythroid enucleation that appears to act independently of its known role in regulating RNA polymerase II transcription, suggesting the potential for a new CDK9 role. Using a co-immunoprecipitation and mass spectrometry approach, we identified the interactome of CDK9 in differentiating erythroblasts. We show that CDK9 interacts with a RanGTP-NEMP1-Importin-β complex during erythroid terminal differentiation, and inhibition of importin-β in erythroblasts blocks erythroid enucleation. Using imaging analysis and functional assays of enucleating erythroblasts, we show that CDK9 and importin-β co-locate at a critical site of activity opposite to the nucleus before nuclear extrusion and we describe a novel finding that physically links CDK9 and importin-β activity prior to CaM/Ca 2+ signalling and subsequent F-actin activity to achieve enucleation. Key Points: Importin-β physically interacts with CDK9 in erythroid cells and is a novel regulator of erythroid enucleation CDK9 and importin-β are required upstream of CaM/Ca 2+ signalling to enable nuclear extrusion